BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2026-08-21		NCT06441890

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Illinois at Chicago	211

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Illinois	Chicago	United States	238

Clinical trials